The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer
Age ≥18 years.
At least 1 eye that has an intraocular or ocular surface tumor.
The presence of a natural crystalline lens or intraocular lens.
Pupils that can dilate up to at least 3 mm in the study eyes.
Does not meet ALL of the above conditions
Single group
Intalight Dream OCT
Diagnostic testThis is a next-generation swept-source device that has a faster imaging speed and higher sensitivity than the previous generation of frequency-domain OCT devices, which serve as the current standard of care devices.
Heidelberg Spectralis OCT
Diagnostic testThis is the standard of care for optical imaging.
Image quality for participants
Evaluated by next-generation swept-source OCT versus standard OCT for imaging of the eye and any relevant ocular tumors.
Field of view for participants
Evaluated by next-generation swept-source OCT versus standard OCT for imaging of the eye and any relevant ocular tumors.
Click on the lead sponsor to view all of their trials.
Memorial Sloan Kettering Cancer Center
Lead sponsor
Intalight, Inc
Collaborator
